Smith Group Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$763K Buy
6,985
+2,851
+69% +$272K 0.04% 105
2025
Q4
$335K Buy
4,134
+178
+4% +$15.3K 0.02% 157
2025
Q3
$346K Buy
3,956
+161
+4% +$14.4K 0.02% 154
2025
Q2
$315K Sell
3,795
-2,461
-39% -$206K 0.02% 157
2025
Q1
$525K Buy
6,256
+24
+0.4% +$2.23K 0.04% 132
2024
Q4
$574K Buy
6,232
+63
+1% +$6.06K 0.04% 132
2024
Q3
$573K Buy
+6,169
New +$535K 0.05% 96
2017
Q4
Sell
-17,310
Closed -$648K 456
2017
Q3
$648K Sell
17,310
-100
-0.6% -$3.4K 0.02% 196
2017
Q2
$544K Buy
+17,410
New +$503K 0.02% 206

Other funds holding LMAT

Smith Group Asset Management's LMAT Position: Q1 2026 in Review

Smith Group Asset Management increased its LeMaitre Vascular (LMAT) stake by 69% in Q1 2026, buying an estimated $272K and bringing the position to 6,985 shares worth $763K. The position accounts for 0.04% of the portfolio, ranked #105.

Smith Group Asset Management first reported a position in LMAT in Q2 2017 and has held it in 9 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Smith Group Asset Management held 6,985 shares of LeMaitre Vascular worth $763K as of Q1 2026.
  • Smith Group Asset Management bought 2,851 LeMaitre Vascular shares in Q1 2026, an estimated $272K.
  • LeMaitre Vascular made up 0.04% of Smith Group Asset Management's portfolio in Q1 2026, its #105 holding.
  • Smith Group Asset Management first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 9 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Smith Group Asset Management's 13F filing for Q1 2026, filed 18 May 2026.